Baxdrostat Bioavailability and Bioequivalence Study
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to AstraZeneca
Related studies linked through entity extraction aliases.
Phase 1 PK Study to Evaluate the PK of CIN-107 in Subjects With Hepatic Impairment
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study to Determine the Metabolism and Clearance of Baxdrostat
- Status
- COMPLETED
- Phase
- PHASE1
EGFR_IUO 3.20 Clinical Study Protocol
- Status
- WITHDRAWN
- Phase
- NA
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
- Status
- COMPLETED
- Phase
- N/A
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..
- Status
- COMPLETED
- Phase
- PHASE1
Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics
- Status
- COMPLETED
- Phase
- N/A
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL
- Status
- RECRUITING
- Phase
- NA
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
- Status
- COMPLETED
- Phase
- N/A
BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.
- Status
- RECRUITING
- Phase
- PHASE1
RELEVANCE - RWE Study in Unresectable Non-Small Cell Lung Cancer (Stage III) in Canada
- Status
- COMPLETED
- Phase
- N/A
OPTIMISE-CKD Drug Utilization
- Status
- COMPLETED
- Phase
- N/A